← Evidence map

ArticleCancer2013

BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.

Kathryn P Pennington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

56 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

NCT04080284phase 222 enrolled2019
Full record →Abstract, authors, funding and every citing paper · PMID 22811390